SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
+15.88%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$25.9B
AUM Growth
+$2.04B
(+8.5%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-4.29%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
2,383
New
198
Increased
568
Reduced
949
Closed
227
Top Buys
| 1 |
Micron Technology
MU
|
+$91.5M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Arch Capital
ACGL
|
+$42.5M |
| 4 |
Align Technology
ALGN
|
+$42.5M |
| 5 |
Eli Lilly
LLY
|
+$42M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$368M |
| 2 |
Salesforce
CRM
|
+$80.9M |
| 3 |
Microsoft
MSFT
|
+$72M |
| 4 |
Apple
AAPL
|
+$64.6M |
| 5 |
Union Pacific
UNP
|
+$45.1M |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 13.2% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXTN
1726
DELISTED
Exterran Corporation
EXTN
| $214K | ﹤0.01% |
48,600
| – | – |
|
1727
TransUnion
TRU
$17.5B
| $213K | ﹤0.01% |
2,151
-192
| -8% | -$19K |
|
1728
Marcus & Millichap
MMI
$1.26B
| $212K | ﹤0.01% |
+5,700
| New | +$212K |
|
1729
Quince Therapeutics
QNCX
$86.5M
| $211K | ﹤0.01% |
7,600
| – | – |
|
1730
Shenandoah Telecom
SHEN
$728M
| $211K | ﹤0.01% |
4,900
-17,200
| -78% | -$741K |
|
1731
Precision BioSciences
DTIL
$59.1M
| $207K | ﹤0.01% |
830
+57
| +7% | +$14.2K |
|
1732
Ormat Technologies
ORA
$5.51B
| $207K | ﹤0.01% |
2,300
+1,100
| +92% | +$99K |
|
|
JNCE
1733
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $207K | ﹤0.01% |
29,600
-18,800
| -39% | -$131K |
|
1734
ALX Oncology
ALXO
$62.7M
| $206K | ﹤0.01% |
2,400
| – | – |
|
|
AJRD
1735
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $206K | ﹤0.01% |
3,900
-2,600
| -40% | -$137K |
|
1736
PG&E
PCG
$33.5B
| $204K | ﹤0.01% |
16,414
-66,211
| -80% | -$823K |
|
1737
Information Services Group
III
$251M
| $202K | ﹤0.01% |
61,600
| – | – |
|
1738
Quaker Houghton
KWR
$2.42B
| $202K | ﹤0.01% |
800
+100
| +14% | +$25.3K |
|
1739
PMV Pharmaceuticals
PMVP
$67.3M
| $202K | ﹤0.01% |
+3,300
| New | +$202K |
|
1740
Protagonist Therapeutics
PTGX
$3.59B
| $201K | ﹤0.01% |
+10,000
| New | +$201K |
|
1741
Workiva
WK
$4.24B
| $201K | ﹤0.01% |
2,200
+1,400
| +175% | +$128K |
|
|
HTLF
1742
DELISTED
Heartland Financial USA, Inc.
HTLF
| $201K | ﹤0.01% |
5,000
+4,600
| +1,150% | +$185K |
|
1743
AXT Inc
AXTI
$155M
| $199K | ﹤0.01% |
20,800
+4,600
| +28% | +$44K |
|
1744
Bandwidth Inc
BAND
$458M
| $199K | ﹤0.01% |
1,300
-300
| -19% | -$45.9K |
|
1745
Sensient Technologies
SXT
$4.51B
| $199K | ﹤0.01% |
2,700
+400
| +17% | +$29.5K |
|
1746
Oneok
OKE
$46.2B
| $198K | ﹤0.01% |
5,160
+472
| +10% | +$18.1K |
|
1747
Conagra Brands
CAG
$9.27B
| $197K | ﹤0.01% |
5,457
-392,527
| -99% | -$14.2M |
|
1748
Vitamin Cottage Natural Grocers
NGVC
$833M
| $195K | ﹤0.01% |
14,200
-22,800
| -62% | -$313K |
|
1749
Apellis Pharmaceuticals
APLS
$3.29B
| $194K | ﹤0.01% |
+3,400
| New | +$194K |
|
1750
Green Plains
GPRE
$635M
| $194K | ﹤0.01% |
14,800
-9,300
| -39% | -$122K |
|